Total Mind Spa accepts most major health insurances plans!
Transcranial Magnetic Stimulation
The "not-so-alternative anymore" alternative to Antidepressants.
Transcranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression. TMS is typically used when other depression treatments haven't been effective. This treatment for depression involves delivering repetitive magnetic pulses, so it's called repetitive TMS or rTMS.
HOW IT WORKS;
"During an rTMS session, an electromagnetic coil is placed against your scalp near your forehead. The electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the region of your brain involved in mood control and depression. It's thought to activate regions of the brain that have decreased activity in depression.
Though the biology of why rTMS works isn't completely understood, the stimulation appears to impact how the brain is working, which in turn seems to ease depression symptoms and improve mood.
There are different ways to perform the procedure, and techniques may change as experts learn more about the most effective ways to perform treatments."
A myriad of ailments can be relieved and eradicated with TMS treatment.
. . .and that's just scratching the tip of the iceberg. Call us today to schedule a consultation!
But is TMS Safe?
Transcranial Magnetic Stimulation is both non-invasive and non-systemic, which means by nature it has fewer side-effects than other treatments and in many cases there are zero side-effects whatsoever. There is no sedation, and no need to be driven to-and-from appointments.
​
Looking for more?
Scientific & Research Studies
Also available: Express TMS aka iTBS!
iTBS is a specific form of Transcranial Magnetic Stimulation (TMS) therapy called intermittent Theta-Burst Stimulation (iTBS), which is approved by the FDA for the treatment of depression. The exploration of this treatment was first conducted during the Stanford University study, where over 20 individuals that fit the criteria for severe depression volunteered to be part of the research. The volunteers also did not respond to treatment with at least one antidepressant medication.
People suffering from depression are prone to experience bouts of suicidal ideation. They need immediate support and help. While antidepressants are good, they lack the swiftness provided by iTBS. According to Stanford scientists, SAINT works faster than traditional TMS and provides a swift response to the symptoms of depression.
Benefits of iTBS include:
The procedure only takes three days start to finish.
​
Participants see results within a few days from the treatment’s first administration.
​
iTBS is safe and poses no side effects.
​
Currently, iTBS ranks as the best Neuromodulation treatment for depression, ranking above Electroconvulsive Therapy and conventional TMS therapy.
​
Another advantage of the Stanford Accelerated Intelligent Neuromodulation Therapy is that it targets a specific point of the brain, making the treatment targeted and more effective.
​
iTBS could provide a means of rapidly ensuring the safety of suicidal patients in emergency settings due to its short duration and rapid onset of action.
​
Our iTBS services include all meals during your 10hr day sessions.
​
Also included in this package is a 3-day/2-night stay in one of our on-site suites that grants access to our on-site fitness center.
iTBS benefits & differences from rTMS
Case Studies & References:
Twenty-two participants with treatment-resistant depression received open-label iTBS. fcMRI was used to individually target the region of the left DLPFC most anticorrelated with sgACC in each participant. Fifty iTBS sessions (1,800 pulses per session, 50-minute intersession interval) were delivered as 10 daily sessions over 5 consecutive days at 90% resting motor threshold (adjusted for cortical depth). Neuropsychological testing was conducted before and after SAINT.
Before undergoing the therapy, all 21 study participants were severely depressed, according to several diagnostic tests for depression. Afterward, 19 of them scored within the nondepressed range. Although all of the participants had suicidal thoughts before the therapy, none of them reported having suicidal thoughts after treatment.
Magnetic stimulation was performed with a high power Magstim 200 (Magstim Co., Whitland, Dyfed, UK) producing magnetic stimuli with a monophasic waveform. A figure-of-eight coil with external loop diameters of 9 cm was held over the right motor cortex at the optimum scalp position to elicit motor evoked potentials (MEPs) in the contralateral first dorsal interosseous (FDI) muscle.